Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.

Old Articles: <Older 7051-7060 Newer>

National Defense February 2011 Eric Beidel	Putty May Put Soldiers On Fast-Track to Recovery Researchers are making big strides toward developing a putty that can regenerate bone and allow the injured to function normally during the healing process.
Chemistry World January 4, 2011 Andrew Turley	Funding pharma whistleblowers Hedge fund managers say that US whistleblower lawsuits filed against drug companies could provide attractive investment opportunities.
The Motley Fool January 4, 2011 Brian Orelli	A Drug Deal an Options Trader Would Love XOMA licenses its diabetes drug, but retains rights to buy it back.
The Motley Fool January 4, 2011 Seth Jayson	Should You Get Out of Martek Biosciences Before Next Quarter? For the last fully reported fiscal quarter, Martek Biosciences' year-over-year revenue grew 36%, and its AR grew 57%. That's a yellow flag.
The Motley Fool January 4, 2011 Seth Jayson	Here's How Smith & Nephew Is Making You So Much Cash With questionable cash flows amounting to only 8.1% of operating cash flow, Smith & Nephew's cash flows look clean.
The Motley Fool January 3, 2011 Rex Moore	Highest-Yielding Pharma Stocks (You Might Actually Want to Buy) How to combine high yield with low risk.
The Motley Fool January 3, 2011 Brian Orelli	Clinical Trial Results Fail to Inspire Inspire Pharma gets cut in half after a cystic fibrosis trial failure.
The Motley Fool January 3, 2011 Seth Jayson	MedAssets May Be Warning You. Are You Listening? I would not be surprised if there were trouble ahead.
The Motley Fool January 3, 2011 Seth Jayson	Gen-Probe May Be Warning You. Are You Listening? For the last fully reported fiscal quarter, Gen-Probe's year-over-year revenue grew 8%, and its AR grew 28.4%. That's a yellow flag.
The Motley Fool January 3, 2011 Travis Hoium	Inspire Pharmaceuticals Shares Plunged: What You Need to Know The new trading year came in with a loud thud for Inspire Pharmaceuticals when its stock fell 58% this morning.
<Older 7051-7060 Newer> Return to current articles.